Mira Pharmaceuticals (MIRA) Treasury Shares (2024 - 2025)

Mira Pharmaceuticals' (MIRA) quarterly Treasury Shares came in at $250000.0 in Q1 2025, down 50.0% quarter-over-quarter from $500000.0 in Q4 2024.

Mira Pharmaceuticals (MIRA) Treasury Shares (2024 - 2025) Analysis & Trends

Mira Pharmaceuticals has disclosed Treasury Shares across 2 years of filings, most recently posting $250000.0 for Q1 2025.

Treasury Shares for Q1 2025 came in at $250000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $250000.0 (changed N/A YoY), and the FY2024 annual result was $500000.0, changed N/A from the prior year.
Treasury Shares came in at $250000.0 for Q1 2025 at Mira Pharmaceuticals, down from $500000.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $500000.0 in Q4 2024 to a low of $250000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	3.01 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	76.26 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	77.08 Mn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	1.11 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	-
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	-
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	3.94 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	881.00 Mn
10	Mira Pharmaceuticals	23.69 Mn	12.66 Mn	-	-

Download Data